Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.

Kalincik T;Spelman T;TROIANO, Maria;Duquette P;Izquierdo G;Grammond P;Lugaresi A;Hupperts R;Cristiano E;Van Pesch V;Grand'maison F;La Spitaleri D;Rio ME;Flechter S;Oreja Guevara C;Giuliani G;Savino A;Amato MP;Petersen T;Fernandez Bolanos R;Bergamaschi R;Iuliano G;Boz C;Lechner Scott J;Deri N;Gray O;Verheul F;Fiol M;Barnett M;van Munster E;Santiago V;Moore F;Slee M;Saladino ML;Alroughani R;Shaw C;Kasa K;Petkovska Boskova T;den Braber Moerland L;Chapman J;Skromne E;Herbert J;Poehlau D;Needham M;Bacile EA;Arruda WO;Paine M;Singhal B;Vucic S;Cabrera Gomez JA;Butzkueven H;IAFFALDANO, PIETRO;MSBase Study Group;PAOLICELLI, DAMIANO

2013-01-01